Basilea Pharmaceutica Deutschland GmbH
- Pharmaceutical Sales 2009
-
worldwide: 17.3 million CHF
in Germany: 9.55 million €
- Product Range
-
Focus: Dermatology, Infectious Diseases
Indications: novel therapeutic approach to treat eczema, novel drugs for bacterial and fungal infections - Key Research Areas
- Dermatology, Infectious Diseases, Oncology
- R&D Expenditure 2009
-
worldwide: 77.2 million CHF
in Germany: -
- Employees in the Pharmaceuticals Division 2009
-
worldwide: more than 300
in Germany: 36
(All data based on corporate information, as of: 05/2010)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page